INTERSTITIAL LUNG DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Inhaled treprostinil aims to slow IPF lung damage in major trial
Disease control CompletedThis Phase 3 trial tested whether an inhaled drug called treprostinil (Tyvaso) could slow the loss of lung function in 598 adults with idiopathic pulmonary fibrosis (IPF), a progressive lung disease. Participants inhaled the drug or a placebo four times daily for 52 weeks. The ma…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a lung drug stop COVID scarring?
Disease control CompletedThis study tested whether nintedanib, a drug used for other lung diseases, can slow down lung damage in people who had severe COVID-19. It included 103 adults who still had lung problems more than 30 days after their COVID diagnosis. The main goal was to see if the drug helped ma…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Inhaled drug shows promise for managing tough Lung-Heart condition
Disease control CompletedThis study looked at the long-term safety of an inhaled medication called treprostinil palmitil (TPIP) for people with pulmonary hypertension caused by interstitial lung disease. Thirty-one adults who completed a previous study took part. The main goal was to check for side effec…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for sarcoidosis patients: inhaled drug targets lung and heart strain
Disease control CompletedThis study tested an inhaled medication called treprostinil in 5 people with sarcoidosis who also have lung scarring and high blood pressure in the lungs. The goal was to see if the drug could improve blood flow and heart function. Participants took the drug and were monitored wi…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Inhaled treprostinil shows promise for exercise capacity in PAH-ILD patients
Disease control CompletedThis study looked at how an inhaled drug called treprostinil helps patients with pulmonary hypertension caused by interstitial lung disease. Researchers measured heart function and breathing efficiency during exercise after 3 months of treatment. The goal was to understand how th…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a chemo combo save lungs in scleroderma patients?
Disease control CompletedThis study tested whether a combination of the chemotherapy drug cyclophosphamide and the steroid prednisone could help people with scleroderma-related lung disease. Forty adults whose lung function had worsened in the past year received either the drug combo or a placebo plus pr…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 16:08 UTC
-
Exercise program shows promise for lung condition patients
Symptom relief CompletedThis study looked at whether a 10-week supervised aerobic exercise program can help people with pulmonary hypertension (high blood pressure in the lungs) become more active and feel better. About 97 participants, including healthy volunteers and patients, took part. Patients were…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Simple breathing device shows promise for lung disease fatigue
Symptom relief CompletedThis study tested whether using a Lung Boost breathing trainer could improve lung function and reduce fatigue in people with interstitial lung disease. Forty women with the condition used the device three times a week for eight weeks. Researchers measured their lung capacity, oxy…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 26, 2026 15:02 UTC
-
Lung disease mystery: 1500 patients to be tracked for clues
Knowledge-focused CompletedThis study follows 1500 adults with interstitial lung disease to understand how the condition changes over time. Researchers will track symptoms, lung function, and treatments used. The goal is to build a detailed picture of the disease's course and improve future care.
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
New approach to CPR talks may help patients and families feel heard
Knowledge-focused CompletedThis study tested a new way for doctors to discuss CPR with older, seriously ill patients and their families. Instead of the usual conversation, doctors followed a step-by-step guide that focused on the patient's values and explained why CPR might not help. The goal was to see if…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2, PHASE3 • Sponsor: University of Vermont • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New screening method could catch hidden lung complication early
Knowledge-focused CompletedThis study looked at ways to screen for pulmonary hypertension (high blood pressure in the lungs) in people who already have interstitial lung disease. The goal was to find this complication earlier. 314 adults with various types of lung disease took part in the screening tests.
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: United Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
New app aims to help chronic patients breathe easier while walking
Knowledge-focused CompletedThis study tested how easy and acceptable the P-STEP mobile app is for people with chronic conditions like asthma, COPD, heart disease, or diabetes. 178 adults in Leicester, UK used the app for 12 weeks to track their walking and get air quality updates. The main goal was to meas…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Ultrasound vs. blood test: which better measures lung severity?
Knowledge-focused CompletedThis study looked at 86 ICU patients with a lung condition called interstitial syndrome. Researchers compared a lung ultrasound score with a standard blood oxygen test to see if the ultrasound could reliably measure how severe the condition was. They repeated both tests at the st…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Which lung test is best for scleroderma patients?
Knowledge-focused CompletedThis study compared two commercially available devices that measure how well the lungs transfer nitric oxide and carbon monoxide. Nine adults with systemic sclerosis and related lung disease took part. Each person was tested with both devices in random order to see if the results…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: Holger Dressel • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study tracks COVID vaccine durability in chronic illness patients
Knowledge-focused CompletedThis completed study followed 360 adults and children with chronic respiratory and other medical conditions to see how their immune systems responded to COVID-19 vaccines over 18 months. Researchers measured antibody, T cell, and B cell levels before vaccination and every 3 month…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New study aims to spot lung transplant trouble early
Knowledge-focused CompletedThis study looked at 80 people who had a lung transplant to see if measuring neural respiratory drive (a breathing signal) and a protein called Pro-BNP could predict when their condition might get worse. The goal is to catch problems like infection or rejection early so treatment…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Could a stomach problem harm your lungs? new study investigates
Knowledge-focused CompletedThis completed study from the University of Virginia looked at whether having a hiatal hernia (a stomach issue) is linked to early, undetected lung scarring. Researchers collected blood and lung fluid samples from 14 adults before surgery to measure signs of lung injury. The goal…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New MRI technique aims to sharpen lung images
Knowledge-focused CompletedThis study tested a special MRI technique called Ultra Short Echo Time (UTE) to see if it can take clearer pictures of the lungs than traditional MRI. Researchers collected images and health information from people with and without lung disease to help doctors better understand l…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC